Identification of Active Compounds in Compound Qinlan Oral Liquid Using A Comprehensive Strategy Based on UPLC-Q-TOF-MS,In vitro Activity,and Molecular Docking TechniquesOA
Identification of Active Compounds in Compound Qinlan Oral Liquid Using A Comprehensive Strategy Based on UPLC-Q-TOF-MS,In vitro Activity,and Molecular Docking Techniques
Lu Luo;Yi-Fan Zhao;Meng-Yuan Yang;Zi Xing;Zhi-Jie Zhang;Zhong-Qing Yao;Li-Zhen Wu;Mei-Hong Tong;Remy MacDonald;Lian-Mei Wang
Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China||Pharmacological and Pharmaceutical Sciences,College of Pharmacy,University of Houston,Houston,TX,77030,USAInstitute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,ChinaInstitute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,ChinaInstitute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,ChinaInstitute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,ChinaHeilongjiang Zhenbaodao Pharmaceutical Co.,Ltd.,Heilongjiang,150000,ChinaHeilongjiang Zhenbaodao Pharmaceutical Co.,Ltd.,Heilongjiang,150000,ChinaHeilongjiang Zhenbaodao Pharmaceutical Co.,Ltd.,Heilongjiang,150000,ChinaDepartment of Statistics,George Mason University,Fairfax,VA,USAInstitute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China
Active componentsanti-inflammationcompound Qinlan oral liquidmolecular dockingnetwork pharmacology
Active componentsanti-inflammationcompound Qinlan oral liquidmolecular dockingnetwork pharmacology
《世界中医药杂志（英文版）》 2026 (2)
211-224,14
This project was supported by the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences(CI2021A04013),National Natural Science Foundation of China(82204610),Qihang Talent Program(L2022046),and Fundamental Research Funds for the Central Public Welfare Research Institutes(ZZ15-YQ-041 and ZXKT21029).
评论